These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34924498)

  • 61. Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer.
    Ricordel C; Chaillot L; Vlachavas EI; Logotheti M; Jouannic A; Desvallees T; Lecuyer G; Aubry M; Kontogianni G; Mastrokalou C; Jouan F; Jarry U; Corre R; Le Guen Y; Guillaudeux T; Lena H; Chatziioannou A; Pedeux R
    Sci Rep; 2023 Mar; 13(1):3626. PubMed ID: 36869231
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.
    Chen B; Li H; Liu C; Wang S; Zhang F; Zhang L; Li M; Li G
    World J Surg Oncol; 2020 Aug; 18(1):226. PubMed ID: 32847588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells.
    Stickler S; Rath B; Hochmair M; Lang C; Weigl L; Hamilton G
    Oncol Res; 2023; 31(1):13-22. PubMed ID: 37303738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.
    Tendler S; Kanter L; Lewensohn R; Ortiz-Villalón C; Viktorsson K; De Petris L
    PLoS One; 2020; 15(10):e0240973. PubMed ID: 33104707
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
    Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
    Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value of delta-like protein 3 combined with thyroid transcription factor-1 in small-cell lung cancer.
    Yan LX; Liu YH; Li Z; Luo DL; Li YF; Yan JH; Zhang JT; Liu C; Liu XH; He J
    Oncol Lett; 2019 Sep; 18(3):2254-2261. PubMed ID: 31452726
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody-Drug Conjugates.
    Belluomini L; Sposito M; Avancini A; Insolda J; Milella M; Rossi A; Pilotto S
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer.
    Savarese-Brenner B; Heugl M; Rath B; Schweizer C; Obermayr E; Stickler S; Hamilton G
    Anticancer Res; 2022 Jan; 42(1):429-439. PubMed ID: 34969753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models.
    Morimura O; Minami T; Kijima T; Koyama S; Otsuka T; Kinehara Y; Osa A; Higashiguchi M; Miyake K; Nagatomo I; Hirata H; Iwahori K; Takimoto T; Takeda Y; Kida H; Kumanogoh A
    Biochem Biophys Res Commun; 2017 Jul; 488(4):596-602. PubMed ID: 28526406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Study of small-cell lung cancer cell-based sensor and its applications in chemotherapy effects rapid evaluation for anticancer drugs.
    Guohua H; Hongyang L; Zhiming J; Danhua Z; Haifang W
    Biosens Bioelectron; 2017 Nov; 97():184-195. PubMed ID: 28599178
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 72. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
    Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
    Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC.
    Uprety D; Remon J; Adjei AA
    J Thorac Oncol; 2021 Sep; 16(9):1429-1433. PubMed ID: 34425994
    [No Abstract]   [Full Text] [Related]  

  • 74. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
    Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
    Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
    Doerr F; George J; Schmitt A; Beleggia F; Rehkämper T; Hermann S; Walter V; Weber JP; Thomas RK; Wittersheim M; Büttner R; Persigehl T; Reinhardt HC
    Sci Rep; 2017 Nov; 7(1):15511. PubMed ID: 29138515
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Medical treatment of small cell lung cancer: Can we leave the area of cisplatin-etoposide?].
    Pujol JL; Roch B; Pujol CN; Goze C
    Bull Cancer; 2018 Oct; 105(10):955-966. PubMed ID: 30100047
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer.
    Desai A; Abdayem P; Adjei AA; Planchard D
    Lung Cancer; 2022 Jan; 163():96-106. PubMed ID: 34942494
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in antibody therapeutics targeting small-cell lung cancer.
    Lu H; Jiang Z
    Adv Clin Exp Med; 2018 Sep; 27(9):1317-1323. PubMed ID: 29790694
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metastasis: Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Moser D; Hochmair M
    Trends Cancer; 2016 Apr; 2(4):159-160. PubMed ID: 28741567
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.
    Qiu Z; Lin A; Li K; Lin W; Wang Q; Wei T; Zhu W; Luo P; Zhang J
    Drug Des Devel Ther; 2019; 13():2021-2041. PubMed ID: 31417239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.